compass_positive_tagline-01.png
COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
04. Januar 2022 07:00 ET | COMPASS Pathways
Study demonstrates feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support London, UK – 4 January...